| ROIVANT SCIENCES |
| Hong Kong (China) |
| Gesundheit |
| BMG762791017 / A3C4MS |
| 87S (Frankfurt) / ROIV (NASDAQ) |
| FRA:87S, ETR:87S, 87S:GR, NASDAQ:ROIV |
| - |
| https://www.roivant.com/ |
|
Roivant Sciences Ltd. is an American multinational healthcare company that develops transformative medicines and technologies by creating agile, focused subsidiaries called Vants. These Vants target specific therapeutic areas, including autoimmune di..
>Volltext.. |
| 16342.93 Mio. EUR |
| 13204.91 Mio. EUR |
| 11.51 Mio. EUR |
| -1047.22 Mio. EUR |
| -699.69 Mio. EUR |
| -1.01 EUR |
| 94.19 Mio. EUR |
| 1280.41 Mio. EUR |
| -656.34 Mio. EUR |
| 29.83 |
| -87.97% |
| -511.61% |
| - |
| - |
| - |
| ROIVANT |
| 02.04.26 |
|
||||
|